Nykode Therapeutics

Developer of vaccines and immunotherapeutics for cancer and infectious diseases

placeOslo, Oslo, Norway calendar_todayFounded 2006 groups102 employees language nykode.com

Registered entities

Innovation

22 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 1,080 times.

YearFilings
20151
20171
20181
20213
202215
202312
202412
202511
20261

Social engagement

Social engagement: 11.4K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital467%
Private equity117%
Other / undisclosed117%

Recent activity

27 May 2026
Milestone
regulatory
Coming soon